StageZero Life Sciences (TSX:SZLS) Days Payable : 562.98 (As of Sep. 2023)

View and export this data going back to 2001. Start your Free Trial

What is StageZero Life Sciences Days Payable?

StageZero Life Sciences's average Accounts Payable for the three months ended in Sep. 2023 was C$4.82 Mil. StageZero Life Sciences's Cost of Goods Sold for the three months ended in Sep. 2023 was C$0.78 Mil. Hence, StageZero Life Sciences's Days Payable for the three months ended in Sep. 2023 was 562.98.

The historical rank and industry rank for StageZero Life Sciences's Days Payable or its related term are showing as below:

TSX:SZLS' s Days Payable Range Over the Past 10 Years
Min: 93.3 Med: 476.91 Max: 1563.02
Current: 371.91

During the past 13 years, StageZero Life Sciences's highest Days Payable was 1563.02. The lowest was 93.30. And the median was 476.91.

TSX:SZLS's Days Payable is ranked better than
87.62% of 210 companies
in the Medical Diagnostics & Research industry
Industry Median: 68.79 vs TSX:SZLS: 371.91

StageZero Life Sciences's Days Payable increased from Sep. 2022 (272.87) to Sep. 2023 (562.98). It may suggest that StageZero Life Sciences delayed paying its suppliers.

StageZero Life Sciences Days Payable Historical Data

The historical data trend for StageZero Life Sciences's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StageZero Life Sciences Days Payable Chart

StageZero Life Sciences Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

590.44

568.79

139.66

93.30

152.69

StageZero Life Sciences Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Payable	Get a 7-Day Free Trial															272.87	209.24	412.49	449.86	562.98

Competitive Comparison of StageZero Life Sciences's Days Payable

For the Diagnostics & Research subindustry, StageZero Life Sciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

StageZero Life Sciences's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, StageZero Life Sciences's Days Payable distribution charts can be found below:

* The bar in red indicates where StageZero Life Sciences's Days Payable falls into.

StageZero Life Sciences Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

StageZero Life Sciences's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (0.941	+	3.832)	/	2 )	/	5.705	*	365
=	2.3865					/	5.705	*	365
=	152.69

StageZero Life Sciences's Days Payable for the quarter that ended in Sep. 2023 is calculated as:

	Days Payable (Q: Sep. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (4.671	+	4.966)	/	2 )	/	0.781	*	365 / 4
=	4.8185					/	0.781	*	365 / 4
=	562.98

StageZero Life Sciences Days Payable Related Terms

Thank you for viewing the detailed overview of StageZero Life Sciences's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

StageZero Life Sciences (TSX:SZLS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » StageZero Life Sciences Ltd (TSX:SZLS) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

SZLSF:USA 61N1:Germany

Address

70 East Beaver Creek Road, Unit 30, Richmond Hill, ON, CAN, L4B 3B2

Website

https://www.stagezerolifesciences.com

StageZero Life Sciences Ltd is a vertically integrated healthcare company at the nexus of three sectors of healthcare; Early Cancer Detection, Liquid Biopsy, and Global Telehealth. It is focused on minimizing the risk of cancer and other chronic diseases through early detection and intervention. It continues to develop and commercialize proprietary molecular diagnostic tests for the early detection of diseases and personalized health management, with a focus on cancer-related indications. It has developed a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. The Company's lead product, Aristotle, is a blood-based molecular diagnostic assessment that can detect an individual's current risk for potentially having a variety of cancers.

StageZero Life Sciences (TSX:SZLS) Headlines

No Headlines